China is one of the most important strategic markets for many life sciences companies. But navigating its constantly changing regulatory environment presents challenges. To successfully seize opportunity in China, companies need to keep up-to-date with its legal requirements and devise sensible commercial strategies to address them.
During this teleconference our Shanghai-based Life Sciences team, Katherine Wang, Geoffrey Lin and Arthur Mok, gave an overview of key regulations and legislative proposals released in 2012 impacting the China Life Sciences. They also offered commentary on the opportunities and risks they all present.
Stay Up To Date with Ropes & Gray
Ropes & Gray attorneys provide timely analysis on legal developments, court decisions and changes in legislation and regulations.
Stay in the loop with all things Ropes & Gray, and find out more about our people, culture, initiatives and everything that’s happening.
We regularly notify our clients and contacts of significant legal developments, news, webinars and teleconferences that affect their industries.